Results 261 to 270 of about 165,707 (370)

Simulation-based training in ear, nose and throat skills and emergencies. [PDF]

open access: yesBraz J Otorhinolaryngol, 2023
Mk G   +5 more
europepmc   +1 more source

First‐Line Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective, Multicenter, Real‐World Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Background In Europe, pembrolizumab with or without chemotherapy is the recommended first‐line treatment for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC), with a combined positive score (CPS) ≥ 1. In France, the TPExtreme (TPEx) regimen is preferred for CPS < 1.
Alizée Simon   +6 more
wiley   +1 more source

Pretreatment Neutrophil‐to‐Lymphocyte Ratio (NLR) Predicts Treatment Toxicity and Intolerance in Operable Head and Neck Cancer: An Ambispective Cohort Study

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Pretreatment neutrophil to lymphocyte ratio (NLR) is a negative prognostic marker for survival in head and neck cancer (HNC). Its association with treatment toxicity and intolerance in patients undergoing curative‐intent surgery is unknown. Methods Ambispective study of patients with operable stage II–IV, HPV‐negative HNC treated at
Raisa Chowdhury   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy